Publication: Nature 561, S48-S49 (2018); doi: 10.1038/d41586-018-06708-3

Author: Anna Nowogrodzki


Even in comparison to other types of cancer, brain cancer is particularly deadly. People with glioblastoma multiforme, one of the most common forms of brain cancer, have a median survival of less than 15 months after diagnosis. The US Food and Drug Administration (FDA) has so far approved only five drugs for treating brain cancer. Given this limited range, researchers could search for potential treatments among the wider pool of all FDA-approved drugs; however, any found to be effective would probably work in just a slim percentage of people with brain cancer.

Read full article here: 

Subscribe to our newsletter

Stay up-to-date on the latest advancements in 3D cell culture technology